investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Charles M. Rudin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Nathanael Schiander Gray

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Trachea, bronchus and lung

Simon D Spivack

Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker

Trachea, bronchus and lung

Hugo Aerts

Genotype and Imaging Phenotype Biomarkers in Lung Cancer

Trachea, bronchus and lung

Peter S Hammerman

Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer

Trachea, bronchus and lung

Tyshia Kyree Gwin

Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoprotein

Trachea, bronchus and lung

Thomas W Valente

The Global Diffusion of Tobacco Control

Trachea, bronchus and lung

Jonathan M Kurie

Regulation of Lung Cancer Metastasis by ZEB1

Trachea, bronchus and lung

Matthew L. Meyerson

How do genome alterations cause human lung cancer?

Trachea, bronchus and lung

Mark G. Kris

Targets for Therapy for Carcinomas of the Lung

Trachea, bronchus and lung